Chemoinformaics analysis of demethoxyaschantin
| Molecular Weight | 370.401 | nRot | 4 |
| Heavy Atom Molecular Weight | 348.225 | nRig | 25 |
| Exact Molecular Weight | 370.142 | nRing | 5 |
| Solubility: LogS | -5.253 | nHRing | 3 |
| Solubility: LogP | 2.739 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 54.5514 |
| nHD | 0 | BPOL | 32.4866 |
| QED | 0.821 |
| Synth | 3.629 |
| Natural Product Likeliness | 0.749 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.996 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.971 |
| MDCK | 0.0000734 |
| BBB | 0.184 |
| PPB | 0.954903 |
| VDSS | 1.416 |
| FU | 0.0274356 |
| CYP1A2-inh | 0.085 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.868 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.57 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.754 |
| CYP2d6-sub | 0.923 |
| CYP3a4-inh | 0.953 |
| CYP3a4-sub | 0.745 |
| CL | 11.991 |
| T12 | 0.094 |
| hERG | 0.247 |
| Ames | 0.403 |
| ROA | 0.077 |
| SkinSen | 0.421 |
| Carcinogencity | 0.835 |
| EI | 0.06 |
| Respiratory | 0.191 |
| NR-Aromatase | 0.748 |
| Antiviral | Yes |
| Prediction | 0.505798 |